+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diprivan"

From
From
Diprivan EML - API Insight, 2022 - Product Thumbnail Image

Diprivan EML - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Diprivan EML- Drug Insight, 2019 - Product Thumbnail Image

Diprivan EML- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Diprivan (propofol) is a sedative-hypnotic drug used in anesthetic practice. It is a short-acting intravenous anesthetic agent that produces a rapid onset of sedation and amnesia. It is commonly used for induction and maintenance of general anesthesia, as well as for sedation of mechanically ventilated patients. Diprivan is also used for procedural sedation in the emergency department and intensive care unit. It is a popular choice for anesthetic drugs due to its rapid onset and short duration of action. The Diprivan market is highly competitive, with a number of companies offering the drug. Some of the major players in the market include AstraZeneca, Fresenius Kabi, Hospira, Mylan, and Teva Pharmaceuticals. Show Less Read more